Danish drugmaker Novo Nordisk said several hundred counterfeit units of its diabetes drug Ozempic were being distributed in ...

Earlier in 2025, the U.S. Food and Drug Administration (FDA ... Richard Pratley, MD is a paid Novo Nordisk, Inc. spokesperson. Only Novo Nordisk manufactures FDA-approved semaglutide medicines, ...

As the ultra-processed food (UPF) conversation continues ... The project was backed by the Novo Nordisk Foundation, the controlling shareholder of the big pharma business famous for making diabetes ...

Novo Nordisk on Saturday said its diabetes pill Rybelsus showed cardiovascular benefits in a late-stage trial, paving the way for it to become a new treatment option for people living with ...

Novo Nordisk agreed to pay up to $2 billion for the rights to ... hormones and is in early-stage clinical development for the treatment of obesity, type 2 diabetes, and other diseases.

Novo Nordisk Warns Consumers About Counterfeit Versions of Ozempic in US (Reuters) - Danish drugmaker Novo Nordisk said on Monday several hundred counterfeit units of its diabetes drug Ozempic ...